Danaher Corporation

242.73+0.1400+0.06%Vol 544.55K1Y Perf 56.18%
Apr 16th, 2021 11:16 DELAYED
BID242.68 ASK242.78
Open243.38 Previous Close242.59
Pre-Market- After-Market-
 - -%  - -
Target Price
242.31 
Analyst Rating
Strong Buy 1.43
Potential %
-0.06 
Finscreener Ranking
★★+     48.92
Insiders Trans % 3/6/12 mo.
-100/-90/-86 
Value Ranking
★★     46.52
Insiders Value % 3/6/12 mo.
-100/-67/-69 
Growth Ranking
★★★★     61.60
Insiders Shares Cnt. % 3/6/12 mo.
-100/-66/-65 
Income Ranking
★+     38.92
Market Cap173.08B 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
93.71 
Earnings Date
22nd Apr 2021

Today's Price Range

241.52243.88

52W Range

151.37248.86

5 Year PE Ratio Range

12.9061.30

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
4.40%
1 Month
12.36%
3 Months
2.47%
6 Months
6.66%
1 Year
56.18%
3 Years
141.58%
5 Years
158.17%
10 Years
367.30%

TickerPriceChg.Chg.%
DHR242.730.14000.06
AAPL133.96-0.5400-0.40
GOOG2 295.00-1.6600-0.07
MSFT259.500.00000.00
XOM56.990.01000.02
WFC43.351.11002.63
JNJ160.970.58000.36
FB306.06-1.7600-0.57
GE13.45-0.1000-0.74
JPM153.241.07000.70
Financial StrengthValueIndustryS&P 500US Markets
1.40
1.90
0.36
0.61
17.30
Leverage Ratio 2.10
ProfitabilityValueIndustryS&P 500US Markets
56.00
21.40
29.40
17.90
17.09
RevenueValueIndustryS&P 500US Markets
17.94B
25.16
4.10
-0.10
DividendsValueIndustryS&P 500US Markets
0.36
0.84
8.49
6.19
Payout ratio16.00
Earnings HistoryEstimateReportedSurprise %
Q04 20201.842.0813.04
Q03 20201.371.7225.55
Q02 20201.061.4435.85
Q01 20201.001.055.00
Q04 20191.261.281.59
Q03 20191.151.160.87
Q02 20191.151.193.48
Q01 20191.011.075.94
Earnings Per EndEstimateRevision %Trend
3/2021 QR1.677.05Positive
6/2021 QR1.787.23Positive
12/2021 FY7.495.20Positive
12/2022 FY8.045.93Positive
Next Report Date22nd Apr 2021
Estimated EPS Next Report1.67
Estimates Count8
EPS Growth Next 5 Years %13.70
Volume Overview
Volume544.55K
Shares Outstanding713.07M
Trades Count8.31K
Dollar Volume1.00B
Avg. Volume2.65M
Avg. Weekly Volume2.82M
Avg. Monthly Volume2.52M
Avg. Quarterly Volume2.62M

Danaher Corporation (NYSE: DHR) stock closed at 242.59 per share at the end of the most recent trading day (a 2.23% change compared to the prior day closing price) with a volume of 2.30M shares and market capitalization of 173.08B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 69000 people. Danaher Corporation CEO is Rainer M. Blair.

The one-year performance of Danaher Corporation stock is 56.18%, while year-to-date (YTD) performance is 9.21%. DHR stock has a five-year performance of 158.17%. Its 52-week range is between 151.37 and 248.86, which gives DHR stock a 52-week price range ratio of 93.71%

Danaher Corporation currently has a PE ratio of 47.10, a price-to-book (PB) ratio of 4.49, a price-to-sale (PS) ratio of 9.33, a price to cashflow ratio of 26.60, a PEG ratio of 2.32, a ROA of 4.88%, a ROC of 7.10% and a ROE of 10.37%. The company’s profit margin is 17.09%, its EBITDA margin is 29.40%, and its revenue ttm is $17.94 Billion , which makes it $25.16 revenue per share.

Of the last four earnings reports from Danaher Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $1.67 for the next earnings report. Danaher Corporation’s next earnings report date is 22nd Apr 2021.

The consensus rating of Wall Street analysts for Danaher Corporation is Strong Buy (1.43), with a target price of $242.31, which is -0.06% compared to the current price. The earnings rating for Danaher Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Danaher Corporation has a dividend yield of 0.36% with a dividend per share of $0.84 and a payout ratio of 16.00%.

Danaher Corporation has a Buy technical analysis rating based on Technical Indicators (ADX : 11.28, ATR14 : 7.06, CCI20 : 165.69, Chaikin Money Flow : 0.16, MACD : 0.46, Money Flow Index : 81.47, ROC : 6.92, RSI : 50.93, STOCH (14,3) : 82.25, STOCH RSI : 1.00, UO : 61.39, Williams %R : -17.75), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Danaher Corporation in the last 12-months were: Angela S. Lalor (Option Excercise at a value of $4 457 124), Angela S. Lalor (Sold 92 377 shares of value $18 894 670 ), Brian W. Ellis (Sold 9 592 shares of value $1 880 100 ), Daniel A. Raskas (Option Excercise at a value of $2 236 537), Daniel A. Raskas (Sold 65 471 shares of value $12 742 105 ), Daniel L. Comas (Option Excercise at a value of $8 900 234), Daniel L. Comas (Sold 172 693 shares of value $35 176 090 ), Elias A. Zerhouni (Option Excercise at a value of $979 928), Elias A. Zerhouni (Sold 8 898 shares of value $2 079 593 ), Joakim Weidemanis (Option Excercise at a value of $731 280), Joakim Weidemanis (Sold 19 834 shares of value $3 887 464 ), John T. Schwieters (Option Excercise at a value of $638 371), John T. Schwieters (Sold 12 028 shares of value $2 332 806 ), Linda Hefner Filler (Option Excercise at a value of $638 371), Linda Hefner Filler (Sold 10 884 shares of value $2 402 196 ), Matthew R. McGrew (Sold 7 457 shares of value $1 516 925 ), Mitchell P. Rales (Buy at a value of $29 447 937), Rainer M. Blair (Sold 6 660 shares of value $1 105 274 ), Robert S. Lutz (Option Excercise at a value of $2 282 856), Robert S. Lutz (Sold 58 486 shares of value $11 214 734 ), Thomas P. Joyce (Option Excercise at a value of $11 953 087), Thomas P. Joyce (Sold 181 294 shares of value $35 167 159 ), Walter G. Lohr (Option Excercise at a value of $638 371), Walter G. Lohr (Sold 136 028 shares of value $26 283 440 ), William H. King (Option Excercise at a value of $1 465 367), William H. King (Sold 26 982 shares of value $5 371 877 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
10 (71.43 %)
10 (71.43 %)
9 (75.00 %)
Moderate Buy
2 (14.29 %)
2 (14.29 %)
1 (8.33 %)
Hold
2 (14.29 %)
2 (14.29 %)
2 (16.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.43
Strong Buy
1.43
Strong Buy
1.42

Danaher Corporation

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which adds to its life sciences segment.

CEO: Rainer M. Blair

Telephone: +1 202 828-0850

Address: 2200 Pennsylvania Avenue, North West, Washington 20037-1701, DC, US

Number of employees: 69 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

58%42%

Bearish Bullish

60%40%

Bearish Bullish

51%49%

News

Stocktwits